SEARCH

SEARCH BY CITATION

References

  • [1] 
    United Nations Office on Drugs and Crime. 2007 World Drug Report. Vienna: Vienna International Centre, 2007.
  • [2] 
    Australian Institute of Health and Welfare. 2004 National Drug Strategy Household Survey: Detailed Findings. Drug Statistics Series No. 16 Cat. no. PHE 66. Canberra: AIHW, 2005.
  • [3] 
    McKetin R, McLaren J, Kelly E, Hall W, Hickman M. Estimating the number of regular and dependent methamphetamine users in Australia. Technical Report No. 230. Sydney: NDARC, UNSW, 2005.
  • [4] 
    Australian Institute of Health and Welfare. Alcohol and other drug treatment services in Australia 2006–07: report on the National Minimum Data Set. Drug treatment series no. 8. Cat. no. HSE 59. Canberra: AIHW, 2008.
  • [5] 
    Brecht ML, Greenwell L, Anglin MD. Methamphetamine treatment: trends and predictors of retention and completion in a large state treatment system (1992–2002). J Subst Abuse Treat 2005;29:295306.
  • [6] 
    Shearer J, Gowing L. Pharmacotherapies for problematic psychostimulant use: a review of current research. Drug Alcohol Rev 2004;23:20311.
  • [7] 
    Simon S, Dacey J, Glynn S, Rawson R, Ling W. The effect of relapse on cognition in abstinent methamphetamine users. J Subst Abuse Treat 2004;27:5966.
  • [8] 
    Lee N, Johns L, Jenkinson R, et al. Clinical treatment guidelines for alcohol and drug clinicians. No 14: methamphetamine dependence and treatment. Fitzroy, Victoria: Turning Point Alcohol and Drug Centre Inc., 2007.
  • [9] 
    Dawe S, McKetin R. The psychiatric comorbidity of psychostimulant use. In: BakerA, LeeNK, JennerLL, eds. Models of intervention and care for psychostimulant users NDS Monograph No 32, 2nd edn. Canberra: Commonwealth of Australia, 2004.
  • [10] 
    Klee H, Morris J. Factors that lead young amphetamine misusers to seek help: implications for drug prevention and harm reduction. Drugs Educ Prev Pol 1994;1:28997.
  • [11] 
    Kolind T. Form or content: the application of user perspectives in treatment research. Drugs Educ Prev Pol 2007;13:26175.
  • [12] 
    McLaughlin DF, McKenna H, Leslie JC. The perceptions and aspirations illicit drug users hold toward health care staff and the care they receive. J Psychiatr Ment Health Nurs 2000;7:43541.
  • [13] 
    Neale J, Sheard L, Tompkins C. Factors that help injecting drug users to access and benefit from services: a qualitative study. Subst Abuse Treat Prev Policy 2007;2(31).
  • [14] 
    Schulte S, Moring J, Meier PS, Barrowclough C. User involvement and desired service developments in drug treatment: service user and provider views. Drugs Educ Prev Pol 2007;14:27787.
  • [15] 
    Treloar C, Abelson J, Cao W, et al. Barriers and incentives to treatment for illicit drug users. Canberra: Australian Government, Department of Health and Ageing, 2004
  • [16] 
    Wright S, Klee H, Reid P. Attitudes of amphetamine users towards treatment services. Drugs Educ Prev Pol 1999;6:7186.
  • [17] 
    Bronson M, Swift R, Peers E. Withdrawal charts: a clinical tool for the management of drug withdrawal symptoms. Aust Nurs J 2005;12:1921.
  • [18] 
    Srisurapanont M, Jarusuraisin N, Kittirattanapaiboon P. Treatment for amphetamine withdrawal. Cochrane Database Syst Rev 2001(4).